Healthcare
Wednesday, January 18, 2017
BRIEF-Takeda Pharmaceutical & Ovid Therapeutics announces clinical development,commercialization collaboration for TAK-935
* Takeda and Ovid Therapeutics announce innovative clinical
development, commercialization collaboration for TAK-935 in rare
pediatric epilepsies
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment